Aurobindo Pharma Limited has submitted a regulatory filing to inform the National Stock Exchange of India Limited and BSE Limited about its participation in an investor/analyst meeting.
The Company officials will participate in the Bank of America 2026 Asia Pacific Conference scheduled for September 21, 2026. The meeting will take place in Hong Kong from 09:00 AM to 5:00 PM (HKT) and will include both one-on-one and group meetings.
The disclosure specifically states that no unpublished price sensitive information (UPSI) is intended to be discussed during these interactions. The company noted that the schedule is subject to change due to exigencies on the part of either the investor or the company.
The letter was digitally signed by B. Adi Reddy, Company Secretary, on September 11, 2026, at 15:18:12 +05:30.